Epidermal Growth Factor Receptor (EGFR)-RAS Signaling Pathway in Penile Squamous Cell Carcinoma

• Hong-Feng Gou ,

  Contributed equally to this work with: Hong-Feng Gou, Xiang Li, Meng Qiu, Ke Cheng

  Affiliation Department of Medical Oncology, Cancer Center, The State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China

  ⨯
• Xiang Li ,

  Contributed equally to this work with: Hong-Feng Gou, Xiang Li, Meng Qiu, Ke Cheng

  Affiliation Department of Urology, West China Hospital, West China Medical School, Sichuan University, Chengdu, China

  ⨯
• Meng Qiu ,

  Contributed equally to this work with: Hong-Feng Gou, Xiang Li, Meng Qiu, Ke Cheng

  Affiliation Department of Medical Oncology, Cancer Center, The State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China

  ⨯
• Ke Cheng ,

  Contributed equally to this work with: Hong-Feng Gou, Xiang Li, Meng Qiu, Ke Cheng

  Affiliation Department of Medical Oncology, Cancer Center, The State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China

  ⨯
• Long-Hao Li,

  Affiliation Department of Medical Oncology, Cancer Center, The State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China

  ⨯
• Hang Dong,

  Affiliation Department of Medical Oncology, Cancer Center, The State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China

  ⨯
• Ye Chen,

  Affiliation Department of Medical Oncology, Cancer Center, The State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China

  ⨯
• Yuan Tang,

  Affiliation Department of Pathology, West China Hospital, West China Medical School, Sichuan University, Chengdu, China

  ⨯
• Feng Gao,

  Affiliation Department of Medical Oncology, Cancer Center, The State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China

  ⨯
• Feng Zhao,

  Affiliation Department of Medical Oncology, Cancer Center, The State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China

  ⨯
• Hai-Tao Men,

  Affiliation Department of Medical Oncology, Cancer Center, The State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China

  ⨯
• Jun Ge,

  Affiliation Department of Medical Oncology, Cancer Center, The State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China

  ⨯
• Jing-Mei Su,

  Affiliation Department of Medical Oncology, Cancer Center, The State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China

  ⨯
• Feng Xu,

  Affiliation Department of Medical Oncology, Cancer Center, The State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China

  ⨯
• Feng Bi,

  Affiliation Department of Medical Oncology, Cancer Center, The State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China

  ⨯
• Jian-Jun Gao ,

  * E-mail: liujiyan1972@163.com (JYL); JGao1@mdanderson.org (JJG)

  Affiliation Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
•  [ ... ],
• Ji-Yan Liu

  * E-mail: liujiyan1972@163.com (JYL); JGao1@mdanderson.org (JJG)

  Affiliation Department of Medical Oncology, Cancer Center, The State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China

  ⨯
• [ view all ]
• [ view less ]